Week 4 of college football brings thrilling matchups! No. 16 Utah faces No. 17 Texas Tech in a key Big 12 battle, while reigning champs Arizona State take on Baylor. Can Nebraska upset Michigan? Plus, BYU tests its mettle against East Carolina!
NASA's VIPER rover is making a comeback, set to launch to the moon in 2027 with Blue Origin. This mission aims to explore water ice at the lunar south pole, crucial for future space endeavors.
The iPhone Air has arrived, and our first impressions reveal it might just be the new standard for smartphones. Discover why this ultra-thin model feels like the new normal and what you need to know!
Discover the exciting new features of the Pokémon TCG Mega Evolution Battle Pass! Unlock powerful decks, booster packs, and exclusive rewards as you battle your way through. Level up your gameplay and collect them all!
The iPhone 17 is here, and reviewers are raving! Discover why choosing the standard model no longer means missing out on top features. Get ready to explore the latest from Apple.
A newly discovered dome-skulled dinosaur named Zavacephale rinpoche from Mongolia offers fresh insights into the evolution of pachycephalosaurs, overturning long-held beliefs about their skull development.
The Expedition 73 crew aboard the ISS welcomed a cargo delivery packed with science supplies and care packages from home. NASA astronaut Jonny Kim shared sweet moments and groundbreaking research highlights from their mission.
Frank Bisignano, appointed by Trump, has ignited a firestorm by suggesting raising the retirement age for American workers. Progressives are outraged, claiming it contradicts Trump’s promises. Could this mean smaller checks for seniors?
In a startling incident, KXTV's offices in Sacramento were targeted by gunfire amidst protests over the suspension of Jimmy Kimmel Live! Thankfully, no injuries were reported as police investigate the motive behind the shooting.
Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
